Neulasta Biosimilar Armlupeg FDA Approved to Prevent Infection – Cure Today

“We are proud to achieve the FDA approval for our first biosimilar, [Armlupeg],” said Vinita Gupta, CEO, Lupin, in the news release. “This step …